You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.
In PLOS this week: cancer predisposition syndromes among pediatric cancer patients, analysis of Plasmodium vivax population genomics in Panama, and more.
In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.
Researchers are hoping to make the technology a success for the environment and human health while avoiding the biases that resulted from the debate over GMOs.
In PLOS this week: gene expression in muscle stem cells, blood metabolomic study of diabetic retinopathy complications, and more.
The findings gave insight into how Plasmodium falciparum persists as a subclinical infection during the dry season, when there are no mosquitoes to transmit it.
In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.
In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.
The diagnostics are capable of detecting fewer than two parasites per microliter of blood and would cost an estimated $.61 per test.
In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.